No Clear Answers From MS Drug Discontinuation Trial Uncategorized / June 20, 2022 The first randomized trial to examine if older adults with multiple sclerosis can discontinue disease-modifying therapy after years of being relapse-free failed to deliver a definitive conclusion. Medscape Medical News